ATE348165T1 - Peptide und nachweis zur diagnose von lyme- krankheit und zusammensetzungen zu deren verhütung - Google Patents

Peptide und nachweis zur diagnose von lyme- krankheit und zusammensetzungen zu deren verhütung

Info

Publication number
ATE348165T1
ATE348165T1 AT00926350T AT00926350T ATE348165T1 AT E348165 T1 ATE348165 T1 AT E348165T1 AT 00926350 T AT00926350 T AT 00926350T AT 00926350 T AT00926350 T AT 00926350T AT E348165 T1 ATE348165 T1 AT E348165T1
Authority
AT
Austria
Prior art keywords
peptide
lyme disease
peptides
compositions
preventing
Prior art date
Application number
AT00926350T
Other languages
English (en)
Inventor
Mario T Philipp
Fang Ting Liang
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Application granted granted Critical
Publication of ATE348165T1 publication Critical patent/ATE348165T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT00926350T 1999-04-28 2000-04-25 Peptide und nachweis zur diagnose von lyme- krankheit und zusammensetzungen zu deren verhütung ATE348165T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/300,971 US6475492B1 (en) 1999-04-28 1999-04-28 Peptides and assays for the diagnosis of lyme disease

Publications (1)

Publication Number Publication Date
ATE348165T1 true ATE348165T1 (de) 2007-01-15

Family

ID=23161382

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00926350T ATE348165T1 (de) 1999-04-28 2000-04-25 Peptide und nachweis zur diagnose von lyme- krankheit und zusammensetzungen zu deren verhütung

Country Status (8)

Country Link
US (1) US6475492B1 (de)
EP (1) EP1171605B1 (de)
AT (1) ATE348165T1 (de)
AU (1) AU767955B2 (de)
CA (1) CA2370493C (de)
DE (1) DE60032347T2 (de)
ES (1) ES2278605T3 (de)
WO (1) WO2000065064A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0894143B2 (de) * 1996-02-21 2012-04-18 Board Of Regents, The University Of Texas System Vmp-ähnliche sequenzen von pathogener borrelia
EP1012181B1 (de) * 1997-06-30 2006-08-23 The Administrators Of The Tulane Educational Fund Oberflächenantigene und proteine für zusammensetzungen zu diagnose und vorbeugung der lyme-kkrankheit
US20030129680A1 (en) * 2001-10-31 2003-07-10 O'connor Thomas Patrick Multi-analyte assay device
US7087372B2 (en) 2001-01-18 2006-08-08 Idexx Laboratories, Inc. Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US7407770B2 (en) 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
AU2003299872A1 (en) 2002-12-20 2004-07-22 Board Of Regents, The University Of Texas System Vmp-like sequences of pathogenic borrelia species and strains
CA2637600A1 (en) 2006-01-17 2007-07-26 Health Research, Inc. Heteroduplex tracking assay
WO2007133623A2 (en) * 2006-05-10 2007-11-22 Biopeptides Corporation Peptide diagnostic agent for lyme disease
US7964366B2 (en) 2007-09-21 2011-06-21 Idexx Laboratories, Inc. Methods and compositions for detection of Ehrlichia chaffeensis (VLPT)
BRPI0816437B8 (pt) 2007-09-21 2021-05-25 Idexx Lab Inc polipeptídeos purificados e métodos para a detecção de ehrlichia chaffeensis em uma amostra teste
US8313915B2 (en) * 2009-01-21 2012-11-20 Gundersen Lutheran Medical Foundation, Inc. Early detection of canine lyme disease by specific peptides and antibodies
FR2949472B1 (fr) 2009-08-28 2013-08-09 Biomerieux Sa Proteines utilisees pour le diagnostic d'une borreliose de lyme
FR2949473B1 (fr) * 2009-08-28 2013-08-09 Biomerieux Sa Proteines utilisees pour le diagnostic d'une borreliose de lyme
US8568989B2 (en) * 2009-11-17 2013-10-29 Abaxis, Inc. Peptides and methods for the detection of Lyme disease antibodies
US8926989B2 (en) * 2010-03-10 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compositions and methods for screening for Lyme disease
KR20130101067A (ko) 2010-09-27 2013-09-12 코넬 유니버시티 라임병의 진단 방법
US10100092B2 (en) 2011-11-03 2018-10-16 Vca, Inc. Compositions and methods to detect various infectious organisms
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
DE102012006498B4 (de) 2012-03-29 2019-08-14 Audi Ag Verfahren zum Betreiben einer Brennkraftmaschine, Brennkraftmaschine sowie Prüfstand
US9500648B1 (en) 2013-03-12 2016-11-22 Robert M. Tate, Jr. Rapid Lyme antigen test for detection of Lyme disease
US11061028B2 (en) 2014-09-24 2021-07-13 Defined Diagnostics, Llc Compositions and methods for the diagnosis of lyme disease
JP2018526645A (ja) 2015-08-27 2018-09-13 クイデル コーポレーション ２つ以上の分析物の検出および区別のための２つの流体流路を有する免疫アッセイ試験装置
WO2017062535A2 (en) 2015-10-06 2017-04-13 Bio-Rad Laboratories, Inc. Borrelia immunoassays and materials therefor
US10401358B1 (en) 2016-09-30 2019-09-03 Ross Southern Laboratories Serodiagnosis of lyme disease by use of two recombinant proteins in ELISA
AU2018219320B2 (en) 2017-02-10 2025-02-27 Ortho-Clinical Diagnostics, Inc. Lateral flow assay with substrate having channels for controlled fluid flow
CN111018998B (zh) * 2019-12-04 2021-10-29 杭州傲锐生物医药科技有限公司 一种莱姆重组融合蛋白OspC-VlsE及其应用
WO2023215783A1 (en) * 2022-05-04 2023-11-09 Kephera Diagnostics, Llc Method for detecting lyme disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
CH485551A (de) 1967-11-02 1970-02-15 Haensel Otto Gmbh Verfahren und Vorrichtung zum Einwickeln von Warenstücken
EP0339695A3 (de) 1988-04-29 1990-05-30 Stichting Voor De Technische Wetenschappen Verfahren zur Herstellung eines antigenen bzw. immunogenen Konjugats sowie die Verwendung solcher Konjugate
DE59010422D1 (de) 1989-12-22 1996-08-22 Mikrogen Molekularbiol Entw Immunologisch aktive proteine von borrelia burgdorferi, zusammenhängende testkits und impfstoff
DE69122240T2 (de) 1990-03-05 1997-02-13 The United States of America, represented by the Secretary, U.S. Department of Commerce, Washington, D.C. Antigen-wirkende proteine von borrelia burgdorferi
SG47447A1 (en) 1990-06-15 1998-04-17 Univ Yale Compositions and methods for the prevention and diagnosis of lyme disease
EP0465204B1 (de) 1990-07-06 2000-09-20 American Home Products Corporation Impfstoff gegen die Lyme-Krankheit
EP0894143B2 (de) * 1996-02-21 2012-04-18 Board Of Regents, The University Of Texas System Vmp-ähnliche sequenzen von pathogener borrelia
EP1012181B1 (de) 1997-06-30 2006-08-23 The Administrators Of The Tulane Educational Fund Oberflächenantigene und proteine für zusammensetzungen zu diagnose und vorbeugung der lyme-kkrankheit

Also Published As

Publication number Publication date
WO2000065064A1 (en) 2000-11-02
EP1171605A1 (de) 2002-01-16
DE60032347D1 (de) 2007-01-25
EP1171605B1 (de) 2006-12-13
CA2370493C (en) 2010-09-21
DE60032347T2 (de) 2007-07-12
ES2278605T3 (es) 2007-08-16
AU4489300A (en) 2000-11-10
US6475492B1 (en) 2002-11-05
CA2370493A1 (en) 2000-11-02
AU767955B2 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
ATE348165T1 (de) Peptide und nachweis zur diagnose von lyme- krankheit und zusammensetzungen zu deren verhütung
CA2175567A1 (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
DE60026332D1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
FI20050243A7 (fi) Stabiilia bakterisidista/läpäisevyyttä parantavaa proteiinifragmenttia koodittava DNA, vektori, isäntäsolu ja menetelmä näiden proteiinipigmenttien valmistamiseksi
KR0176265B1 (en) Causative agent of the mystery swine disease, and vaccine compositions
DE69718903T2 (de) Verwendung von aus osp-c abgeleiteten peptidefragmenten für diagnostische methoden
CA2224127A1 (en) Flagellin gene, flac of campylobacter
WO1995014781A3 (en) Methods for diagnosing early lyme disease
EP1278534A4 (de) Zusammensetzungen und verfahren zur behinderung der vervielfältigung von hiv-1
IL95742A0 (en) Recombinant polypeptides and peptides,nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis
CA2332570A1 (en) Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine
CA2175332A1 (en) Haemophilus transferrin receptor genes
DE1240180T1 (de) Peptide zur diagnose und behandlung rheumatischer arthritis
JPH04502904A (ja) 両親媒性ペプチドの投与方法およびその組成物
ATE267397T1 (de) Reagenz zum nachweis und weiterverfolgen von virusinfektionen
ZA907944B (en) Hiv related peptides
CA2262500A1 (en) Measles virus mutant antigen and gene coding for the same
CA2486345A1 (en) Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
JP2003189884A5 (de)
EP0953642A4 (de) Antigenprotein aus infektiöse laryngotracheitis viren
JPH0770184A (ja) 牛の小型ピロプラズマ病原虫感染の予防に有効なペプチド

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties